Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.34−0.03 (-2.19%)
Close on Nov 18, 2026Market cap $4.89MP/E –Yield –
Pulmatrix net income
Net income is the profit left for shareholders after every expense, interest and tax.
Pulmatrix's net income for the twelve months ending Sep 30, 2026 was -$4.35M. For fiscal 2025 it was -$5.16M. The highest annual figure on record is -$5.16M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.16M | – |
| FY2024 | Dec 31, 2024 | -$9.56M | – |
| FY2023 | Dec 31, 2023 | -$14.12M | – |
| FY2022 | Dec 31, 2022 | -$18.84M | – |
| FY2021 | Dec 31, 2021 | -$20.17M | – |
| FY2020 | Dec 31, 2020 | -$19.31M | – |
| FY2019 | Dec 31, 2019 | -$20.60M | – |
| FY2018 | Dec 31, 2018 | -$20.56M | – |
| FY2017 | Dec 31, 2017 | -$18.06M | – |
| FY2016 | Dec 31, 2016 | -$27.84M | – |
| FY2015 | Dec 31, 2015 | -$26.17M | – |
| FY2014 | Dec 31, 2014 | -$24.14M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.21M | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.04M | – |
| Q1 FY2026 | Mar 31, 2026 | -$1.17M | – |
| Q4 FY2025 | Dec 31, 2025 | -$928.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$877.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$1.55M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.81M | -319.2% |
| Q4 FY2024 | Dec 31, 2024 | -$1.99M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.59M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.81M | – |
| Q1 FY2024 | Mar 31, 2024 | $825.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.08M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.77M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.82M | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.45M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.22M | – |
| Q3 FY2022 | Sep 30, 2022 | -$5.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.60M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.97M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.03M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.18M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.85M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.10M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.90M | – |
| Q3 FY2020 | Sep 30, 2020 | -$10.55M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.17M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.69M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.04M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.56M | – |
| Q2 FY2019 | Jun 30, 2019 | -$7.84M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.16M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.22M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.82M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.19M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.22M | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.52M | – |
| Q3 FY2017 | Sep 30, 2017 | -$4.45M | – |
| Q2 FY2017 | Jun 30, 2017 | -$5.60M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.48M | – |
| Q4 FY2016 | Dec 31, 2016 | -$9.83M | – |
See a number that looks wrong?